Search clinical trials for: raltegravir potassium

Total 1965 results

Humanis Saglık Anonim Sirketi

Completed

Bioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated Tablet

Analgesic | Non-steroidal Anti-inflammatory (NSAID) | Antipyretic

Jordan
Organon and Co

Completed

Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)

Hypertension
Merck Sharp & Dohme LLC

Completed

MK-0954E Study in Participants With Hypertension (MK-0954E-357)

Hypertension
Northwestern University

Withdrawn

Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus

Diabetes Mellitus | HF - Heart Failure

United States
John Elfar
University of Arizona

Active, not recruiting

4-aminopyridine Treatment for Nerve Injury

Prostate Cancer | Nerve Injury

United States
Federal University of São Paulo

Completed

Fluid Therapy During Brain Tumor Resection in Children

Brain Neoplasms

Brazil
Acorda Therapeutics

Completed

Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury

Muscle Spasticity | Spinal Cord Injury

United States, Canada
Federal University of Uberlandia

Completed

Assessment of Different Protocols for Cervical Dentin Hypersensitivity Treatment (CDH)

Dentin Sensitivity | Dentin Hypersensitivity | Dentine Hypersensitivity | Hypersensitivity Dentin

Brazil
Acorda Therapeutics

Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial

Multiple Sclerosis

United States, Canada
Diakonhjemmet Hospital

Completed

Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter

Atrial Fibrillation | Atrial Flutter

Norway
London Health Sciences Centre

Completed

Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients?

Cognitive Fatigue

Canada
Acorda Therapeutics

Completed

Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy

Cerebral Palsy (CP)

United States
Bristol-Myers Squibb
Cardioxyl Pharmaceuticals, Inc

Completed

A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure

Heart Failure | Decompensated Heart Failure | Acute Heart Failure

United States, Germany, Jordan, Poland, Russian Federation
University of Rochester

Withdrawn

4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic Prostatectomy

Prostate Disease

United States
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Completed

Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism (ACTICAS)

Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment

France
Hospital Civil de Guadalajara

Completed

The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide.

Cardiorenal Syndrome

Mexico
Yonsei University

Withdrawn

A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)

Congestive Heart Failure
Teva Pharmaceuticals USA

Completed

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions

Healthy

United States
Organon and Co

Terminated

A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)

Hypertension
D'Youville College
University at Buffalo; Acorda Therapeutics

Completed

Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple Sclerosis

Multiple Sclerosis
Henan Cancer Hospital

Terminated

Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer

Advanced Cancer

China
Karolinska Institutet
Karolinska University Hospital

Completed

Effects of Nitrate in Vegetables on Blood Pressure in Subjects With Prehypertension (DINO)

Hypertension | Cardiovascular Disease

Sweden
University of Florida
Acorda Therapeutics

Completed

Dalfampridine and Gait in Spinocerebellar Ataxias

Spinocerebellar Ataxias Type 1 | Spinocerebellar Ataxias Type 2 | Spinocerebellar Ataxias Type 3 | Spinocerebellar Ataxias Type 6

United States
Cancer Institute and Hospital, Chinese Academy...
Chinese PLA General Hospital; Peking University Cancer Hospital & Institute; Tianjin... and other collaborators

Unknown

Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer

Breast Cancer

China
Zhejiang Cancer Hospital

Recruiting

Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (Stars)

Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma

China
Centre Hospitalier Universitaire de Besancon

Completed

Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine. (FAMPISEP)

Multiple Sclerosis

France
University of Southern Denmark
Biogen; Region of Southern Denmark

Completed

Resistance Training and Amino Pyridine in Multiple Sclerosis (RETRAP)

Multiple Sclerosis

Denmark
Procter and Gamble

Completed

A Study to Evaluate Oral Malodor and Other Outcomes Following The Use of Two-Step Toothpaste Oral Hygiene

Oral Malodor

United States
Neuro-Ophthalmologic Associates, PC
Acorda Therapeutics

Completed

A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) (Ampyra)

Non Arteritic Ischemic Optic Neuropathy

United States
Yokohama City University

Unknown

S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

Head and Neck Cancer

Japan
Jan Calissendorff

Recruiting

Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter

Hyperthyroidism

Sweden
Acorda Therapeutics

Completed

Study of Fampridine-SR Tablets in Multiple Sclerosis Patients

Multiple Sclerosis

United States, Canada
Acorda Therapeutics

Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial

Multiple Sclerosis

United States, Canada
University of Rochester
National Institute of Neurological Disorders and Stroke (NINDS); Rare Diseases... and other collaborators

Terminated

Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome

Andersen-Tawil Syndrome

United States
Sanofi

Completed

Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension (COSIMA2)

Hypertension

India, Malaysia, Philippines, Singapore, Taiwan, Tunisia, Egypt, Korea, Republic of, Hong Kong, Indonesia, Morocco, Pakistan, Thailand, Vietnam
Johns Hopkins University
Acorda Therapeutics

Completed

Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)

Neuromyelitis Optica | Transverse Myelitis | Idiopathic Transverse Myelitis | Myelitis NOS

United States
Peking University Cancer Hospital & Institute
Peking University People's Hospital; Peking Union Medical College Hospital; Cancer...

Recruiting

SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

Adjuvant Chemotherapy | Colorectal Cancer Stage III

China
Yu jiren

Active, not recruiting

Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer (FOCUS-02)

Gastric Cancer Stage III

China
Procter and Gamble

Completed

A Clinical Study to Determine the Safety and Effectiveness of Dentinal Hypersensitivity Treatment With Two Different Toothbrushes

Dentin Sensitivity

United States
Centre Hospitalier Universitaire de Saint Etienne

Terminated

Performance of Diuretic Stress Test in Predicting Short Term Renal Recovery in Oliguric Critically-ill Patients Recovery in the Short Term

Critical Illness | Oliguria

France
Clinique Neuro-Outaouais
CogState Ltd.

Completed

Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients

Multiple Sclerosis

Canada
Cairo University

Completed

Furosemide and Coarctation Surgery Lung Complications

Pulmonary Complication

Egypt
Stanford University
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

The Use of Prophylactic Antibiotics In the Management of Dog Bites

Infection | Wound | Bite

United States
Abramson Cancer Center at Penn Medicine
Genentech, Inc.

Recruiting

CAR-T Followed by Bispecific Antibodies

DLBCL - Diffuse Large B Cell Lymphoma | Large B-cell Lymphoma

United States
Prof. Dominique de Quervain, MD
University Hospital, Basel, Switzerland; Clinical Trial Unit, University Hospital...

Active, not recruiting

Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment (FamC)

Working Memory | Post-covid-19

Switzerland
European University of Lefke

Completed

Effect of Dalfampridine in Patients With Hereditary Spastic Paraplegia

Hereditary Spastic Paraplegia

Cyprus
Assiut University

Unknown

Influence of Diuresis Timing (F+0 Vs F-15) on 99m Tc DTPA Renography for the Diagnosis of Suspected Obstructive Uropathy

Renal Scan in Suspected Obstructive Uropathy in Adult Hydronephrotic Patient
Instituto Nacional de Cardiologia Ignacio Chavez

Unknown

Furosemide Stress Test as a Predictor of Tubular Function in Chronic Kidney Disease (FST-IFTA)

Chronic Kidney Disease

Mexico
University of Campania "Luigi Vanvitelli"

Completed

Loop Diuretics in Chronic Kidney Disease

Chronic Kidney Disease

Italy
Medical Centre Leeuwarden

Terminated

Forced Diuresis Versus Observation in Resolving Renal Failure After Haemofiltration in Critically Ill Patients

Renal Failure | Critically Ill

Netherlands

Search clinical trials for: raltegravir potassium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations